Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE11.3050
- TODAY'S CHANGE (%)0.0950 (0.8475%)
- Bid / Lots11.3000/ 100
- Ask / Lots11.3100/ 60
- Open / Previous Close11.2600 / 11.2100
- Day Range
- 52 Week Range
- Volume2,295,862
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 45625 | 11.33 |
| 09:34 ET | 4350 | 11.29 |
| 09:36 ET | 10648 | 11.305 |
| 09:38 ET | 7603 | 11.31 |
| 09:39 ET | 6920 | 11.32 |
| 09:41 ET | 5111 | 11.325 |
| 09:43 ET | 10982 | 11.315 |
| 09:45 ET | 1867 | 11.315 |
| 09:48 ET | 46852 | 11.33 |
| 09:50 ET | 4739 | 11.325 |
| 09:52 ET | 10130 | 11.335 |
| 09:54 ET | 6417 | 11.335 |
| 09:56 ET | 9705 | 11.325 |
| 09:57 ET | 5094 | 11.31 |
| 09:59 ET | 22627 | 11.32 |
| 10:01 ET | 16610 | 11.325 |
| 10:03 ET | 6598 | 11.315 |
| 10:06 ET | 11976 | 11.32 |
| 10:08 ET | 21531 | 11.355 |
| 10:10 ET | 39627 | 11.34 |
| 10:12 ET | 12923 | 11.355 |
| 10:14 ET | 2060 | 11.355 |
| 10:15 ET | 18552 | 11.365 |
| 10:17 ET | 28992 | 11.365 |
| 10:19 ET | 60431 | 11.375 |
| 10:21 ET | 83832 | 11.37 |
| 10:24 ET | 57623 | 11.35 |
| 10:26 ET | 16232 | 11.31 |
| 10:28 ET | 23532 | 11.295 |
| 10:30 ET | 22854 | 11.29 |
| 10:32 ET | 26722 | 11.315 |
| 10:33 ET | 18796 | 11.325 |
| 10:35 ET | 24031 | 11.35 |
| 10:37 ET | 17410 | 11.345 |
| 10:39 ET | 20422 | 11.325 |
| 10:42 ET | 21791 | 11.345 |
| 10:44 ET | 18920 | 11.335 |
| 10:46 ET | 18413 | 11.335 |
| 10:48 ET | 31039 | 11.32 |
| 10:50 ET | 5137 | 11.315 |
| 10:51 ET | 8815 | 11.335 |
| 10:53 ET | 17247 | 11.345 |
| 10:55 ET | 7689 | 11.335 |
| 10:57 ET | 15134 | 11.335 |
| 11:00 ET | 4189 | 11.33 |
| 11:02 ET | 32391 | 11.345 |
| 11:04 ET | 9741 | 11.345 |
| 11:06 ET | 18560 | 11.335 |
| 11:08 ET | 17767 | 11.335 |
| 11:09 ET | 4638 | 11.345 |
| 11:11 ET | 3396 | 11.345 |
| 11:13 ET | 2351 | 11.35 |
| 11:15 ET | 24564 | 11.33 |
| 11:18 ET | 2793 | 11.32 |
| 11:20 ET | 4521 | 11.315 |
| 11:22 ET | 9366 | 11.3 |
| 11:24 ET | 4976 | 11.285 |
| 11:26 ET | 3915 | 11.28 |
| 11:27 ET | 5307 | 11.275 |
| 11:29 ET | 3131 | 11.28 |
| 11:31 ET | 4200 | 11.28 |
| 11:33 ET | 26084 | 11.275 |
| 11:36 ET | 25281 | 11.265 |
| 11:38 ET | 15443 | 11.26 |
| 11:40 ET | 1055 | 11.26 |
| 11:42 ET | 19431 | 11.255 |
| 11:44 ET | 4493 | 11.275 |
| 11:45 ET | 16774 | 11.27 |
| 11:47 ET | 3570 | 11.27 |
| 11:49 ET | 1665 | 11.2766 |
| 11:51 ET | 6500 | 11.26 |
| 11:54 ET | 10383 | 11.255 |
| 11:56 ET | 8106 | 11.265 |
| 11:58 ET | 2442 | 11.265 |
| 12:00 ET | 9240 | 11.265 |
| 12:02 ET | 11931 | 11.28 |
| 12:03 ET | 4446 | 11.29 |
| 12:05 ET | 1300 | 11.28 |
| 12:07 ET | 13730 | 11.285 |
| 12:09 ET | 6756 | 11.275 |
| 12:12 ET | 10573 | 11.275 |
| 12:14 ET | 2773 | 11.285 |
| 12:16 ET | 1400 | 11.285 |
| 12:18 ET | 3901 | 11.295 |
| 12:20 ET | 13525 | 11.28 |
| 12:21 ET | 1000 | 11.2888 |
| 12:23 ET | 2509 | 11.285 |
| 12:25 ET | 11680 | 11.275 |
| 12:27 ET | 11702 | 11.265 |
| 12:30 ET | 1083 | 11.265 |
| 12:32 ET | 2671 | 11.26 |
| 12:34 ET | 6774 | 11.265 |
| 12:36 ET | 1816 | 11.27 |
| 12:38 ET | 17574 | 11.275 |
| 12:39 ET | 3609 | 11.285 |
| 12:41 ET | 1696 | 11.2893 |
| 12:43 ET | 10498 | 11.295 |
| 12:45 ET | 10568 | 11.295 |
| 12:48 ET | 5315 | 11.3 |
| 12:50 ET | 1606 | 11.3 |
| 12:52 ET | 25416 | 11.285 |
| 12:54 ET | 18224 | 11.285 |
| 12:56 ET | 21382 | 11.29 |
| 12:57 ET | 1840 | 11.285 |
| 12:59 ET | 13406 | 11.275 |
| 01:01 ET | 5758 | 11.28 |
| 01:03 ET | 2089 | 11.285 |
| 01:06 ET | 26648 | 11.285 |
| 01:08 ET | 1146 | 11.285 |
| 01:10 ET | 1120 | 11.285 |
| 01:12 ET | 28181 | 11.285 |
| 01:14 ET | 13060 | 11.3 |
| 01:15 ET | 9599 | 11.3 |
| 01:17 ET | 2157 | 11.295 |
| 01:19 ET | 18364 | 11.315 |
| 01:21 ET | 2700 | 11.315 |
| 01:24 ET | 11060 | 11.315 |
| 01:26 ET | 22353 | 11.315 |
| 01:28 ET | 10659 | 11.3 |
| 01:30 ET | 1407 | 11.305 |
| 01:32 ET | 20266 | 11.305 |
| 01:33 ET | 3541 | 11.3 |
| 01:35 ET | 11775 | 11.305 |
| 01:37 ET | 17351 | 11.29 |
| 01:39 ET | 53063 | 11.295 |
| 01:42 ET | 5787 | 11.295 |
| 01:44 ET | 2012 | 11.295 |
| 01:46 ET | 3074 | 11.295 |
| 01:48 ET | 23504 | 11.285 |
| 01:50 ET | 11814 | 11.295 |
| 01:51 ET | 40291 | 11.29 |
| 01:53 ET | 10746 | 11.28 |
| 01:55 ET | 2776 | 11.29 |
| 01:57 ET | 25605 | 11.3 |
| 02:00 ET | 28219 | 11.29 |
| 02:02 ET | 5027 | 11.29 |
| 02:04 ET | 4681 | 11.2999 |
| 02:06 ET | 8376 | 11.29 |
| 02:08 ET | 18779 | 11.285 |
| 02:09 ET | 10294 | 11.285 |
| 02:11 ET | 576 | 11.28 |
| 02:13 ET | 15122 | 11.295 |
| 02:15 ET | 40640 | 11.285 |
| 02:18 ET | 7669 | 11.295 |
| 02:20 ET | 8753 | 11.295 |
| 02:22 ET | 2106 | 11.295 |
| 02:24 ET | 5473 | 11.3 |
| 02:26 ET | 16375 | 11.32 |
| 02:27 ET | 6421 | 11.315 |
| 02:29 ET | 3401 | 11.31 |
| 02:31 ET | 27008 | 11.305 |
| 02:33 ET | 37418 | 11.305 |
| 02:36 ET | 2214 | 11.305 |
Sep 19, 2024
DJ Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 6:32AM ET on Thursday Sep 19, 2024 by Dow Jones
6:32AM ET on Thursday Sep 19, 2024 by Dow Jones
Sep 18, 2024
DJ Roivant Flips a Skin Drug to Organon -- Barrons.com, from 10:59AM ET on Wednesday Sep 18, 2024 by Dow Jones
10:59AM ET on Wednesday Sep 18, 2024 by Dow JonesDJ Organon to Buy Roivant's Dermavant Unit in Deal Worth Up to $1.2 Billion, from 8:14AM ET on Wednesday Sep 18, 2024 by Dow Jones
8:14AM ET on Wednesday Sep 18, 2024 by Dow JonesPress Release: Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:30AM ET on Wednesday Sep 18, 2024 by Dow JonesOrganon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 8.3B | 2.0x | --- |
Corcept Therapeutics Inc | 4.7B | 39.7x | +9.80% |
Ligand Pharmaceuticals Inc | 1.9B | 46.9x | -12.71% |
Harrow Inc | 1.8B | -52.8x | --- |
Ocular Therapeutix Inc | 1.4B | -8.9x | --- |
Immunocore Holdings PLC | 1.5B | -29.1x | --- |
Company Information
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting the neonatal Fc receptor (FcRn) in development across several IgG-mediated autoimmune indications; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 for the treatment of dermatomyositis and non-infectious uveitis, in addition to other clinical-stage molecules. It advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its pipeline program also includes Mosliciguat.
Contact Information
- Headquarters
- 11-12 St. James's Square Suite 1, 3rd FloorLONDON, United Kingdom SW1Y4LB
- Phone
- 207-400-3347
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ilan Oren
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer, Director
- Mayukh Sukhatme
- Chief Executive Officer, Chief Financial Officer
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.3B |
|---|---|
Revenue (TTM) | $158.3M |
Shares Outstanding | 739.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $5.57 |
Book Value | $7.40 |
P/E Ratio | 2.0x |
Price/Sales (TTM) | 52.4 |
Price/Cash Flow (TTM) | 1.8x |
Operating Margin | 2,799.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
